Analysis of propinoylcarnitine in blood and methylmalonic acid in urine of 162 patients with methylmalonic acidemia

毋盛楠,韩连书,叶军,邱文娟,张惠文,高晓岚,王瑜,李筱燕,许浩
DOI: https://doi.org/10.3760/cma.j.issn.0376-2491.2013.08.001
2013-01-01
Abstract:Objective To analyze the levels of methylmalonic acid and methylcitric acid in urine,propinoylcarnitine (C3) in plasma and C3/acetylcarnitine (C2) of patients with methylmalonic acidemia (MMA) and explore their applications in the diagnosis of MMA.Methods From December 2003 to March 2012,a total of 162 patients with MMA (MMA group) and 200 healthy children (control group) of Xinhua Hospital,Shanghai Jiaotong University School of Medicine were recruited.MMA patients with a definite classification were divided into 2 groups:isolate MMA group (n =51) and MMA complicated with homocysteinemia group (n =65).Gas chromatography-mass spectrometry was used to measure the urine levels of methylmalonic acid and methylcitric acid and tandem mass spectrometry to measure the blood levels of free carnitine (CO),acylcarnitines and methionine (Met).Results In the MMA group,the median levels of methylmalonic acid (259.10 (6.73-6429.28)),methylcitric acid (4.39 (0-248.96)),C3 (8.52 (1.50-52.11) μmoL/L) and C3/C2 (0.73 (0.28-2.89)) were all higher than the upper limit values(0.2-3.6,0-1.1,0.50-4.00 μmol/L and 0.04-0.25 respectively).And they were all higher than those in the control group (0(0-1.87),0.10(0-1.84),1.40(0.53-3.90) μmol/L,0.10(0.04-0.23),all P <0.01).C3/C2 increased significantly in 15 patients while the C3 level remained normal.The median level of Met was normal in the isolate MMA group.But in patients with homocysteinemia,the level of 8.71 (0.68-31.95) μmol/L was below the reference value (10.00-35.00 μmol/L) and lower than that in the isolate MMA group(15.35(4.18-59.50)μmol/L)and the control group(15.59(10.20-34.68) μmol/L,all P<0.05).Conclusions Significant increases in the urine level of methylmalonic acid and C3/C2 may be specific to MMA.Organic acid analyses of gas chromatography-mass spectrometry and acylcarnitines with tandem mass spectrometry are required for a definite diagnosis of this disorder.And repeated tests and genomic mutation analysis are necessary for patients with mildly abnormal biochemical indices.
What problem does this paper attempt to address?